PEA

  • Gunnison Copper Boosts Project Value: Updated PEA Shows $2 Billion Post-Tax NPV

    Gunnison Copper Project’s updated PEA reveals strong economics, with a projected $1.952 billion NPV and 22.7% IRR at $4.60/lb copper. Key enhancements include integrating the Strong & Harris deposit, material sorting, and a cement co-product, significantly boosting value by $692 million compared to the previous study. The project forecasts 174 million lbs of copper annually for 15 years, with competitive cash costs. Gunnison Copper Corp. plans to proceed with a Pre-Feasibility Study.

    Markets 4 days ago
  • Silver X Files: Preliminary Economic Assessment & Updated Mineral Resource Estimate Technical Report

    Silver X Mining Corp. released a Preliminary Economic Assessment (PEA) for its Nueva Recuperada project, targeting 6.2 million ounces of silver equivalent annually over a 14-year mine life. The PEA outlines a $439 million after-tax NPV (5% discount) and a 3-year payback, with an initial CapEx of $82 million. Production is planned across two mills at 3,000 tpd. The study relies on inferred resources, carrying inherent risks, and production decisions are not based on proven reserves or a feasibility study.

    2025年10月23日
  • Prime Announces 2025 AGM Voting Results

    Prime Mining Corp. announced a successful shareholder meeting with all proposals approved and directors elected. The company, focused on its Los Reyes gold-silver project in Mexico, has a strong cash balance and is on track to deliver a Preliminary Economic Assessment in Q3 2025. Shareholder engagement was high, demonstrating confidence in Prime’s future.

    2025年6月19日
  • SciSparc Announces Japanese Patent Application Publication

    SciSparc Ltd. announced a Japanese patent application for a novel pain management therapy. The application covers a combination of paracetamol and palmitoylethanolamide (PEA) designed to enhance pain and fever relief while potentially reducing side effects, including liver damage. This synergistic approach aims to improve treatment outcomes for various pain types and leverage the body’s endocannabinoid system.

    2025年5月27日